CLINICAL_TRIALS
withdrawal
· 2021-09-13
Clinical Trial Update: Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD [Phase 3]
Summary
Phase 3 trial investigating ipratropium/levalbuterol fixed-dose combination versus salbutamol/ipratropium free combination for acute bronchodilator effects in s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: WITHDRAWN